Latest News

FDA Approves Worlds first vaccine against respiratory syncytial virus FDA approved stamp ©Waldenmarus/Adobe Stock
FDA Approves World's First Vaccine Against Respiratory Syncytial Virus

May 3rd 2023

The novel vaccine, from biopharma company GSK, is approved to prevent RSV-associated lower respiratory tract disease in adults aged ≥60 years.

FDA Approves First Oral Microbiota Biotherapeutic for Recurrent C. difficile Infection
FDA Approves First Oral Microbiota Biotherapeutic for Recurrent C. difficile Infection

April 28th 2023

Oral Superabsorbent Hydrogel Cuts Risk for Type 2 Diabetes
Daily Dose: RSV Infection in Infancy & Risk of Asthma in Childhood

April 26th 2023

RSV Infection During Infancy Linked to Higher Risk of Asthma in Childhood
RSV Infection During Infancy Linked to Higher Risk of Asthma in Childhood

April 25th 2023

Fluvoxamine and Inhaled Budesonide: Novel Combination Reduced Incidence of Severe COVID-19 COVID-19 ©Gluiki/Adobe Stock
Fluvoxamine and Inhaled Budesonide: Novel Combination Reduced Incidence of Severe COVID-19

April 24th 2023

© 2023 MJH Life Sciences

All rights reserved.